Holdings (as at 2026-04-15)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.96%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2026-04-15)
Security Name % of Net Assets
Moderna, Inc. 5.41%
United Therapeutics Corporation 4.09%
Axsome Therapeutics, Inc. 4.07%
Corcept Therapeutics Inc. 4.00%
Gilead Sciences, Inc. 3.95%
Alkermes Plc 3.83%
Amgen Inc. 3.65%
argenx SE (ADR) 3.65%
Krystal Biotech, Inc. 3.51%
Exelixis, Inc. 3.44%
BioNTech SE (ADR) 3.41%
Neurocrine Biosciences, Inc. 3.31%
Biogen Inc. 3.29%
Vertex Pharmaceuticals Incorporated 3.26%
BeOne Medicines Ltd. (ADR) 3.24%
Regeneron Pharmaceuticals, Inc. 3.24%
BioMarin Pharmaceutical Inc. 3.21%
Halozyme Therapeutics, Inc. 3.21%
Illumina, Inc. 3.21%
Sarepta Therapeutics, Inc. 3.12%
Incyte Corporation 3.11%
Bio-Techne Corporation 3.04%
Natera, Inc. 3.02%
Genmab A/S (ADR) 2.92%
Alnylam Pharmaceuticals, Inc. 2.86%
ACADIA Pharmaceuticals Inc. 2.78%
Veracyte, Inc. 2.77%
Repligen Corporation 2.70%
Bruker Corporation 2.48%
NeoGenomics, Inc. 2.26%
Dreyfus Government Cash Management (Institutional Shares) 0.03%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.